Healthcare provider profile · identity verified

David Larsen, DO

Family Practice · LONGVIEW, TX · NPI 1609225960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	343	79
Omeprazole	Omeprazole	267	69
Gabapentin	Gabapentin	239	54
Atorvastatin Calcium	Atorvastatin Calcium	237	64
Amlodipine Besylate	Amlodipine Besylate	223	66
Losartan Potassium	Losartan Potassium	223	70
Furosemide	Furosemide	187	45
Rosuvastatin Calcium	Rosuvastatin Calcium	181	65
Potassium Chloride	Potassium Chloride	161	34
Lisinopril	Lisinopril	160	51
Metoprolol Succinate	Metoprolol Succinate	159	41
Eliquis	Apixaban	152	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	34
Tramadol Hcl	Tramadol Hcl	143	34
Sertraline Hcl	Sertraline Hcl	132	22
Pantoprazole Sodium	Pantoprazole Sodium	131	41
Simvastatin	Simvastatin	110	22
Donepezil Hcl	Donepezil Hcl	105	13
Metoprolol Tartrate	Metoprolol Tartrate	102	26
Trazodone Hcl	Trazodone Hcl	97	23
Metformin Hcl Er	Metformin Hcl	95	28
Tamsulosin Hcl	Tamsulosin Hcl	91	25
Alprazolam	Alprazolam	89	22
Montelukast Sodium	Montelukast Sodium	85	28
Xarelto	Rivaroxaban	80	suppressed
Carvedilol	Carvedilol	77	24
Duloxetine Hcl	Duloxetine Hcl	76	23
Bupropion Xl	Bupropion Hcl	75	16
Fluoxetine Hcl	Fluoxetine Hcl	67	15
Hydrochlorothiazide	Hydrochlorothiazide	66	23
Pregabalin	Pregabalin	63	16
Memantine Hcl	Memantine Hcl	62	suppressed
Meloxicam	Meloxicam	61	18
Ozempic	Semaglutide	60	suppressed
Pravastatin Sodium	Pravastatin Sodium	60	20
Metformin Hcl	Metformin Hcl	58	15
Escitalopram Oxalate	Escitalopram Oxalate	57	17
Fluticasone Propionate	Fluticasone Propionate	57	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	15
Ezetimibe	Ezetimibe	55	15
Nitrofurantoin	Nitrofurantoin Macrocrystal	55	suppressed
Digoxin	Digoxin	51	suppressed
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	45	24
Bumetanide	Bumetanide	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Clonazepam	Clonazepam	43	16
Hydroxyzine Hcl	Hydroxyzine Hcl	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	14
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	11
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Cephalexin	Cephalexin	35	16
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Buspirone Hcl	Buspirone Hcl	34	11
Mounjaro	Tirzepatide	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Topiramate	Topiramate	30	suppressed
Estradiol	Estradiol	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	11
Glipizide	Glipizide	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Lorazepam	Lorazepam	27	14
Ramipril	Ramipril	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	18
Famotidine	Famotidine	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Allopurinol	Allopurinol	25	12
Chlorthalidone	Chlorthalidone	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Torsemide	Torsemide	24	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	15
Synthroid	Levothyroxine Sodium	21	suppressed
Budesonide	Budesonide	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	13
Latanoprost	Latanoprost	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Diazepam	Diazepam	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Temazepam	Temazepam	17	suppressed
Prednisone	Prednisone	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Finasteride	Finasteride	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Horizant	Gabapentin Enacarbil	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Methimazole	Methimazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error